Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 DEC 1 ... strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested nearly 9 billion Swiss francs in R&D in 2008. Worldwide, the ...
2009 DEC 3 ... 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake ... on a country, regional, and global level," said Dr. Gerd Maass, CEO of Roche NimbleGen, Inc. For more information about Roche NimbleGen, please visit www.nimblegen.com ...
2009 NOV 30 ... 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake ...
2009 NOV 23 ... Chemistry, 2009;52(19):5816-5825). For more information, contact J. Marik, Genentech Inc., Dept. of Biomedical Imaging, 1 DNA Way, San Francisco, CA 94080, USA. ...
2009 NOV 23 ... the TAP technology are in clinical testing through ImmunoGen's collaborations with Genentech (a wholly-owned member of the Roche Group), sanofi-aventis, Biogen Idec and Biotest. The ... ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, ...
2009 NOV 17 ... package, and wines from some of the world's top vineyards. Corporate sponsors include Genentech, Roche, Merrill Lynch, and Morgan Stanley, among others. All proceeds from ...
2009 NOV 30 ... 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake ... is a trademark of Roche.E-PLATE is a registered trademarks of ACEA Biosciences, Inc. in the US Keywords: Biotechnology, Cancer, Cell Proliferation, ...
2009 NOV 26 ... strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested nearly 9 billion Swiss francs in R&D in 2008. Worldwide, the ...
2009 NOV 16 ... earlier this year. • Carol Garvey, CCDM, director, CDM at Genentech, Inc. Garvey has been in the biotechnology industry for 25 years, including ...
2009 NOV 30 ... 2009;187(1):61-70). For additional information, contact V.M. Dixit, Genentech Inc., Dept. of Physiol Chemical, 460 Point San Bruno Blvd., San Francisco, CA 94080, USA. ...
2009 NOV 16 ... 2009;326(5952):572-574). For additional information, contact R.L. Yauch, Genentech Inc., San Francisco, CA 94080, USA. Publisher contact information for the ...
2009 NOV 16 ... exposures with MabThera have been recorded worldwide since its launch. Genentech and Biogen Idec co-market Rituxan in the United States, and Roche markets MabThera in ...
2009 NOV 16 ... companies, including Bristol-Myers Squibb, sanofi-aventis, GlaxoSmithKline, Genentech, Boehringer Ingelheim, Wyeth Pharmaceuticals, and Daiichi-Sankyo. For more information, ... Exelixis, Inc. (Nasdaq: EXEL) announced that thirteen abstracts related to the company's development ...
2009 NOV 16 ... Prior to VIVUS, Mr. Tam held various research and clinical development positions at Genentech from 1991 through 1993 and XOMA Corporation from 1987 to 1991. Mr. Tam received a B.S. ... VIVUS, Inc. (NASDAQ:VVUS) announced the promotion of Peter Tam to president of VIVUS. In this ...
